Literature DB >> 21282550

Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma.

Paul J Greaves, John G Gribben.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21282550     DOI: 10.1200/JCO.2010.33.2437

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center.

Authors:  Paolo Anderlini; Rima Saliba; Sandra Acholonu; Grace-Julia Okoroji; Celina Ledesma; Borje S Andersson; Roy Jones; Uday R Popat; Chitra M Hosing; Yago Nieto; Muzaffar H Qazilbash; Naoto T Ueno; Sergio A Giralt; Marcos J de Lima; Richard E Champlin
Journal:  Leuk Lymphoma       Date:  2012-01-05

2.  Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.

Authors:  María Marta Rivas; Mariano Berro; María Virginia Prates; Sebastián Yantorno; Lorena Fiad; Jorge Alberto Arbelbide; Ana Lisa Basquiera; Gonzalo Ariel Ferini; Juan José García; Pablo Andrés García; Leandro Riera; Gustavo Jarchum; Alfredo Baso; Juan Real; Martín Castro; Gregorio Jaimovich; Juliana Martinez Rolón; Cecilia Foncuberta; Silvia Saba; Gustavo Kusminsky
Journal:  Bone Marrow Transplant       Date:  2019-08-21       Impact factor: 5.483

Review 3.  Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.

Authors:  Michael D Jain; John Kuruvilla
Journal:  Drugs       Date:  2017-10       Impact factor: 11.431

4.  Outcomes in relapsed Hodgkin's lymphoma treated with autologous and allogeneic hematopoietic cell transplantation at the Pontificia Universidad Católica de Chile.

Authors:  Pablo Ramirez; Mauricio Ocqueteau; Alejandra Rodriguez; Maria Jose Garcia; Mauricio Sarmiento; Daniel Ernst; Veronica Jara; Pablo Bertin
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.